In Supreme Court petition, Merck argues that FDA power shields against liability

6th December 2017 Uncategorised 0

A Merck & Co. appeal in the Fosamax liability litigation has drawn in the U.S. Solicitor General, and with its focus on the FDA’s power to determine official drug labels, the outcome could reverberate across¬†the pharmaceutical industry.

More: In Supreme Court petition, Merck argues that FDA power shields against liability
Source: fierce